Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-02-08 00:00:00 ET · period of report 2023-02-06 · accession 0001209191-23-007772 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-08 | 2023-02-06 | KPTI | Paulson Richard A. | Pres, CEO, Dir | S - Sale | $3.40 | -3,950 | 604.7K | -0.6% | -$13.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-06 | S | D | 3,950 | $3.40 | 604,655 | D | — | — |